Denali Therapeutics
DNLI
#3955
Rank
A$3.55 B
Marketcap
$24.51
Share price
1.23%
Change (1 day)
6.86%
Change (1 year)

Earnings for Denali Therapeutics (DNLI)

Earnings in 2024 (TTM): -A$0.77 Billion

According to Denali Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Denali Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.79 Billion155.15%
2023 -A$0.31 Billion-42.27%
2022 -A$0.54 Billion15.21%
2021 -A$0.47 Billion-571.56%
2020 A$98.02 M-129.42%
2019 -A$0.34 Billion359.73%
2018 -A$72.48 Million-48.56%
2017 -A$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.19 Billion-75.93% Jersey
-A$0.25 Billion-68.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$19.36 Million-97.53%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.12 Billion-85.44%๐Ÿ‡ฌ๐Ÿ‡ง UK